Online inquiry

IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10700MR)

This product GTTS-WK10700MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAMTS16 protein. This product can be used in Secretory progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_139056.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 170690
UniProt ID Q8TE57
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10700MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK20133MR IVTScrip™ mRNA-Human AIM1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AIM1
GTTS-WK23901MR IVTScrip™ mRNA-Human ASB9, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASB9
GTTS-WK12774MR IVTScrip™ mRNA-Human ACTR3C, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACTR3C
GTTS-WK26924MR IVTScrip™ mRNA-Human ASPM, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASPM
GTTS-WK24140MR IVTScrip™ mRNA-Human ARL3, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARL3
GTTS-WK9230MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK28544MR IVTScrip™ mRNA-Human APPL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA APPL2
GTTS-WK27457MR IVTScrip™ mRNA-Human ARMC8, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARMC8
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW